Essa Pharma Inc’s recent filing unveils that its 10% Owner BIOTECH GROWTH N V unloaded Company’s shares for reported $12.02 million on Nov 01 ’24. In the deal valued at $1.53 per share,7,879,583 shares were sold. As a result of this transaction, BIOTECH GROWTH N V now holds 0 shares worth roughly $0.0.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Virsik Peter sold 694 shares, generating $4,185 in total proceeds. Upon selling the shares at $6.03, the Chief Operating Officer now owns 7,776 shares.
Before that, Virsik Peter sold 694 shares. Essa Pharma Inc shares valued at $4,164 were divested by the Chief Operating Officer at a price of $6.00 per share. As a result of the transaction, Virsik Peter now holds 8,470 shares, worth roughly $15246.0.
Piper Sandler downgraded its Essa Pharma Inc [EPIX] rating to a Neutral from a an Overweight in a research note published on November 04, 2024; the price target was decreased to $2 from $15. A number of analysts have revised their coverage, including Oppenheimer’s analysts, who decreased its forecast for the stock in early November from “an Outperform” to “a Perform”. Jefferies also remained covering EPIX and has decreased its forecast on November 04, 2024 with a “Hold” recommendation from previously “Buy” rating.
Price Performance Review of EPIX
On Friday, Essa Pharma Inc [NASDAQ:EPIX] saw its stock jump 1.69% to $1.80. Over the last five days, the stock has gained 28.57%. Essa Pharma Inc shares have fallen nearly -72.73% since the year began. Nevertheless, the stocks have fallen -64.64% over the past one year. While a 52-week high of $11.67 was reached on 02/07/24, a 52-week low of $1.40 was recorded on 11/01/24. SMA at 50 days reached $5.5138, while 200 days put it at $6.4785.
Levels Of Support And Resistance For EPIX Stock
The 24-hour chart illustrates a support level at 1.7468, which if violated will result in even more drops to 1.6935. On the upside, there is a resistance level at 1.8665. A further resistance level may holdings at 1.9329. The Relative Strength Index (RSI) on the 14-day chart is 22.80, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.0986, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 91.29%. Stochastics %K at 7.57% indicates the stock is a buying.
How much short interest is there in Essa Pharma Inc?
A steep rise in short interest was recorded in Essa Pharma Inc stocks on 2024-10-15, growing by 77602.0 shares to a total of 1.15 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-13 was 1.07 million shares. There was a rise of 6.76%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on March 04, 2021 when Piper Sandler began covering the stock and recommended ‘”an Overweight”‘ rating along with a $50 price target.
